Other names for Cetyl Myristoleate

cetyl myristoleate
cetyl myristoleate 20% complex
cetyl-myristoleate, active
cetyl myristoleate (cmo) complex
cetyl myristoleate complex
cmo
cmo complex

Synopsis of Cetyl Myristoleate

History

Cetyl Myristoleate (CMO) is a unique fatty acid ester that has garnered significant attention in the realm of natural health and nutritional supplements. First discovered in the early 1970s by Dr. Harry Diehl, a researcher at the National Institutes of Health, CMO was initially noted for its remarkable ability to reduce joint pain and inflammation in laboratory animals. Inspired by these results, subsequent research explored its potential for alleviating symptoms of arthritis and other inflammatory conditions in humans.

Historically, Cetyl Myristoleate has been embraced as a promising remedy for joint health, especially among those seeking alternatives to conventional pharmaceuticals. Its purported mechanisms include acting as a lubricant for joints and modulating immune responses, thereby reducing inflammation and discomfort. Anecdotal and clinical reports have highlighted its capacity to promote flexibility, mobility, and overall joint comfort, making it a favored ingredient in nutritional products targeting osteoarthritis and rheumatoid arthritis.

In the context of herbal medicine, CMO is often combined with other botanical and nutrient-based remedies such as turmeric, boswellia, MSM (methylsulfonylmethane), and glucosamine. These synergistic combinations are designed to maximize anti-inflammatory effects and support the body's natural healing processes. As an adjunct to herbal therapies, CMO has contributed positively by enhancing the efficacy of these blends, providing holistic and well-tolerated support for individuals managing chronic joint and muscle discomfort.

Overall, Cetyl Myristoleate stands out as a valuable ingredient in natural health products, celebrated for its positive impact on joint health and its role in comprehensive, herbal-based wellness strategies.

Traditional and scientific validation

Cetyl Myristoleate (CMO) is a naturally occurring fatty acid ester first identified in the early 1990s by Dr. Harry Diehl, who reported its potential benefits in supporting joint health. Initially discovered in laboratory experiments where it demonstrated the ability to prevent arthritis in rats, CMO quickly garnered interest as a dietary supplement ingredient. Its proposed mechanism involves lubrication of joint surfaces and modulation of immune responses, potentially reducing inflammation and discomfort associated with joint conditions.

Several small-scale clinical studies have explored the efficacy of Cetyl Myristoleate in humans. Notably, a double-blind, placebo-controlled trial published in the Journal of Rheumatology (1997) found that patients with knee osteoarthritis experienced improved range of motion and reduction in pain after using a topical CMO formulation. Another study in 2002 reported that oral CMO supplementation contributed to improved joint function and decreased stiffness in some individuals with osteoarthritis. These findings suggest that Cetyl Myristoleate may offer a valuable adjunct to traditional approaches for joint care.

However, the total number of rigorous, large-scale clinical trials remains limited, and some experts urge caution, emphasizing the need for further research to conclusively establish CMO’s safety and effectiveness. Nonetheless, anecdotal reports and preliminary investigations have highlighted its potential role in promoting joint comfort and flexibility. As part of a comprehensive approach to joint health, Cetyl Myristoleate continues to be a promising ingredient, warranting ongoing scientific exploration.

Cetyl Myristoleate is used for these health conditions

Arthritis (Scientific)
Inflammation (Scientific)

This ingredient is used to support these body systems

None

Products containing Cetyl Myristoleate

We currently have no products on Vitabase that contain this ingredient.